Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1083 | 972 | 1083 | 1021 | 1170 | 1743 |
Fund Return | 8.29% | -2.76% | 8.29% | 0.69% | 3.18% | 5.71% |
Place in category | 101 | 33 | 101 | 35 | 315 | 103 |
% in Category | 15 | 6 | 15 | 6 | 67 | 34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 9.18B | 34.69 | 8.33 | 12.04 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.59B | 28.90 | 6.79 | 9.56 | ||
UBS CH Vitainvest 50 World U | 4.42B | 8.31 | -0.67 | 2.51 | ||
UBS CH Institutional Fund 2 EquiSCA | 3.14B | 16.90 | 0.55 | 6.47 | ||
UBS CH Institutional Fund 2 EquiSCX | 3.14B | 17.20 | 0.81 | 6.76 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.59B | 7.50 | -0.45 | 5.93 | ||
Raiffeisen Futura Swiss Stock A | 2.2B | 7.81 | -1.29 | 5.90 | ||
CH0502155648 | 2.21B | 9.19 | 1.50 | - | ||
UBS CH Equity Fund Swiss Income CHQ | 2.21B | 9.00 | 1.31 | 6.36 | ||
Pictet CH Institutional Swiss EquiI | 2.13B | 4.62 | -3.37 | 6.35 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 9.63 | 275.20 | +1.85% | |
Novartis | CH0012005267 | 9.43 | 90.33 | +1.09% | |
Nestle | CH0038863350 | 9.34 | 74.48 | -0.35% | |
UBS Group | CH0244767585 | 8.56 | 31.68 | +0.44% | |
Zurich Insurance Group | CH0011075394 | 8.24 | 531.20 | -0.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review